» Articles » PMID: 2522658

Interleukin 1 As an Autocrine Growth Factor for Acute Myeloid Leukemia Cells

Overview
Specialty Science
Date 1989 Apr 1
PMID 2522658
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Production of interleukin 1 (IL-1) by leukemic cells was studied in 13 cases of acute myeloid leukemia. Intracytoplasmic immunofluorescence studies showed that the cells invariably contained the cytokine. Endogenous labeling studies demonstrated that acute myeloid leukemia cells produced either only the 33-kDa propeptide or both the propeptide and the 17-kDa mature form of IL-1 beta. The 33-kDa propeptide IL-1 alpha was always produced but was less frequently released. Involvement of IL-1 in leukemic cell growth was investigated using two antibodies specific for IL-1 subtypes, which inhibited spontaneous cell proliferation in the six cases studied. After acid treatment of the cells, a surface receptor for IL-1 could be demonstrated, which mediated 125I-labeled IL-1-specific uptake by leukemic cells. Furthermore, recombinant IL-1 alpha or IL-1 beta induced significant cell proliferation in 10 of 12 cases. The above findings were uncorrelated with the cytologic type (French-American-British classification) of leukemia. Our studies suggest that IL-1 may act as an autocrine growth factor in most cases of acute myeloid leukemia.

Citing Articles

Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.

Uechi L, Vasudevan S, Vilenski D, Branciamore S, Frankhouser D, OMeally D NPJ Syst Biol Appl. 2024; 10(1):32.

PMID: 38527998 PMC: 10963775. DOI: 10.1038/s41540-024-00352-6.


Insights Regarding the Role of Inflammasomes in Leukemia: What Do We Know?.

Alves-Hanna F, Crespo-Neto J, Nogueira G, Pereira D, Lima A, Ribeiro T J Immunol Res. 2023; 2023:5584492.

PMID: 37577033 PMC: 10421713. DOI: 10.1155/2023/5584492.


The cytokine network in acute myeloid leukemia.

Luciano M, Krenn P, Horejs-Hoeck J Front Immunol. 2022; 13:1000996.

PMID: 36248849 PMC: 9554002. DOI: 10.3389/fimmu.2022.1000996.


The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia.

Urwanisch L, Luciano M, Horejs-Hoeck J Int J Mol Sci. 2021; 22(3).

PMID: 33525345 PMC: 7865748. DOI: 10.3390/ijms22031271.


Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.

Azab E, Chandler K, Uda Y, Sun N, Hussein A, Shuwaikan R FASEB J. 2020; 34(8):10191-10211.

PMID: 32557809 PMC: 7688590. DOI: 10.1096/fj.202000366R.


References
1.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

2.
Cozzolino F, Torcia M, MILIANI A, Carossino A, Giordani R, Cinotti S . Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med. 1988; 84(2):240-50. DOI: 10.1016/0002-9343(88)90420-2. View

3.
Rubartelli A, Sitia R, Zicca A, Grossi C, Ferrarini M . Differentiation of chronic lymphocytic leukemia cells: correlation between the synthesis and secretion of immunoglobulins and the ultrastructure of the malignant cells. Blood. 1983; 62(2):495-504. View

4.
Sporn M, Roberts A . Autocrine growth factors and cancer. Nature. 1985; 313(6005):745-7. DOI: 10.1038/313745a0. View

5.
Schwab R, Crow M, Russo C, Weksler M . Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1. J Immunol. 1985; 135(3):1714-8. View